ARCHIVES

M.D. Anderson Closes Trials following FDA Requests for Data

This article is from The Cancer Letter archive.

Vol. 22 No. 07 | February 16, 1996

Download PDF Visit The Full Archive

Related Articles

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

Nelvis Castro To Serve As Acting OCC Chief; HHS Selects ANA President Malone.

January 7, 2000